Cargando…

Platelet reactivity to thrombin differs between patients with COVID-19 and those with ARDS unrelated to COVID-19

Detalles Bibliográficos
Autores principales:	Zaid, Younes, Guessous, Fadila, Puhm, Florian, Elhamdani, Wail, Chentoufi, Lamyae, Morris, Andrew Conway, Cheikh, Amine, Jalali, Farid, Boilard, Eric, Flamand, Louis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846461/ https://www.ncbi.nlm.nih.gov/pubmed/33560374 http://dx.doi.org/10.1182/bloodadvances.2020003513

Ejemplares similares

Platelets Can Associate With SARS-CoV-2 RNA and Are Hyperactivated in COVID-19
por: Zaid, Younes, et al.
Publicado: (2020)

Low α-Thrombin/GPIbα Interaction Is a Potential Contributor to Platelet Hyper-reactivity in COVID-19 Patients
por: Zaid, Younes, et al.
Publicado: (2023)

High levels of eicosanoids and docosanoids in the lungs of intubated COVID‐19 patients
por: Archambault, Anne‐Sophie, et al.
Publicado: (2021)

Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19
por: Zaid, Younes, et al.
Publicado: (2021)

The ongoing enigma of SARS‐CoV‐2 and platelet interaction
por: Zaid, Younes, et al.
Publicado: (2022)

Type I and III interferons are good markers to monitor COVID-19 pathophysiology
por: Darif, Dounia, et al.
Publicado: (2023)

Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells
por: Puhm, Florian, et al.
Publicado: (2022)

ARDS RELATED TO COVID-19
por: Sekhon, Jasmine, et al.
Publicado: (2020)

COVID-19 pneumonia: ARDS or not?
por: Gattinoni, Luciano, et al.
Publicado: (2020)

Is COVID-19 severity unrelated to antinuclear antibodies?
por: Vahabi, Maedeh, et al.
Publicado: (2023)

ECMO for ARDS due to COVID-19
por: Ñamendys-Silva, Silvio A.
Publicado: (2020)

The decline in stroke hospitalization due to COVID‐19 is unrelated to COVID‐19 intensity
por: Sedova, Petra, et al.
Publicado: (2022)

RESPIRATORY PHYSIOLOGICAL PARAMETERS AND OUTCOMES OF PATIENTS WITH COVID-19 ARDS AND NON-COVID-19 ARDS UNDERGOING ECMO
por: FEDERBUSH, M., et al.
Publicado: (2022)

The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?
por: Darif, Dounia, et al.
Publicado: (2021)

COVID19 seroconversion in an unrelated stem cell donor
por: Maakaron, Joseph E., et al.
Publicado: (2020)

Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice
por: Dubuc, Isabelle, et al.
Publicado: (2022)

BIO-MECHANICS OF ARDS IN COVID-19: A PROSPECTIVE OBSERVATIONAL STUDY
por: Naeem, Ehsun, et al.
Publicado: (2020)

COMPARISON OF COVID-19 PATIENTS ADMITTED TO THE HOSPITAL WITH ARDS AND THOSE WHO PROGRESS TO IT DURING HOSPITALIZATION
por: IMRAN, MARYAM, et al.
Publicado: (2021)

Dissecting Platelet’s Role in Viral Infection: A Double-Edged Effector of the Immune System
por: El Filaly, Hajar, et al.
Publicado: (2023)

Atypical Presentation of COVID-19 Leading to ARDS
por: Williams, Aquino, et al.
Publicado: (2020)

Mechanical ventilation in early COVID-19 ARDS
por: Lepper, Philipp M., et al.
Publicado: (2020)

Intravenous immunoglobulin therapy for COVID-19 ARDS
por: Wilfong, Erin M, et al.
Publicado: (2022)

COVID-19 ARDS-related pneumomediastinum and pneumothorax
por: Marwah, Vikas, et al.
Publicado: (2021)

Lung transplantation for COVID-19-associated ARDS
por: Lepper, Philipp M, et al.
Publicado: (2021)

Lung transplantation for COVID-19-associated ARDS
por: Messika, Jonathan, et al.
Publicado: (2021)

COVID-19 ARDS: getting ventilation right
por: Pérez-Fernández, Xosé L, et al.
Publicado: (2022)

KL-6 in ARDS and COVID-19 Patients
por: Piazza, Ornella, et al.
Publicado: (2022)

ACE2 and COVID-19 and the resulting ARDS
por: Zhang, Xiaoqing, et al.
Publicado: (2020)

Prone Positioning in COVID-19 ARDS: Reply
por: Zarantonello, Francesco, et al.
Publicado: (2023)

Prone Positioning in COVID-19 ARDS: Comment
por: Zhao, Zhanqi, et al.
Publicado: (2023)

Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients
por: Hoechter, D.J., et al.
Publicado: (2020)

COVID-19 ARDS is characterized by higher extravascular lung water than non-COVID-19 ARDS: the PiCCOVID study
por: Shi, Rui, et al.
Publicado: (2021)

D-dimer levels in non-COVID-19 ARDS and COVID-19 ARDS patients: A systematic review with meta-analysis
por: Tóth, Krisztina, et al.
Publicado: (2023)

IMPACT OF TRACHEOSTOMY TIMING ON OUTCOMES IN COVID-19 AND NON-COVID-19 ARDS
por: GERIANI, D., et al.
Publicado: (2022)

Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19
por: Aliter, Kholoud F., et al.
Publicado: (2020)

PRONE POSITIONING IN COVID-19 VS NON-COVID-19 ARDS IN THE EARLY COVID-19 PANDEMIC
por: LIEBERMAN, ALLYSON E, et al.
Publicado: (2022)

Myocarditis, paraparesia and ARDS associated to COVID-19 infection
por: Jeantin, Lina, et al.
Publicado: (2021)

Reinventing the Wheel in ARDS: Awake Proning in COVID-19
por: Sryma, P.B., et al.
Publicado: (2020)

Luftgebundene Intensivverlegung in Bauchlage bei COVID-19-ARDS
por: Schellhaaß, A., et al.
Publicado: (2020)

Impact of late administration of corticosteroids in COVID-19 ARDS
por: Mongardon, Nicolas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jpfaehtjq3fu1i6nvmsrk6if9b